Acquired by TPG Capital in Nov 2022
CNVY - Convey Health Solutions Holdings, Inc.
NYSE
->
Healthcare
->
Health Information Services
Fort Lauderdale,
United States
Type: Equity
CNVY price evolution
CNVY
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $19.71 | $20.87 | $38.81 | $40 |
| Short term investments | ||||
| Net receivables | $71.56 | $72.71 | $62.81 | $46.8 |
| Inventory | $38.57 | $36.41 | $14.06 | $13.86 |
| Total current assets | $141.17 | $140.79 | $132.25 | $113.55 |
| Long term investments | ||||
| Property, plant & equipment | $40.33 | $39.53 | $20.4 | $19.32 |
| Goodwill & intangible assets | $724.65 | $730.55 | $675.22 | $679.76 |
| Total noncurrent assets | $770.54 | $775.74 | $697.65 | $700.8 |
| Total investments | ||||
| Total assets | $911.71 | $916.53 | $829.9 | $814.36 |
| Current liabilities | ||||
| Accounts payable | $8.22 | $11.16 | $13.87 | $11.86 |
| Deferred revenue | $8.16 | $9.49 | $7.47 | $4.66 |
| Short long term debt | $7.25 | $6.89 | $0.5 | $0.49 |
| Total current liabilities | $64.06 | $57.57 | $70.4 | $58.99 |
| Long term debt | $284.38 | $283.55 | $190.17 | $190.14 |
| Total noncurrent liabilities | $316.93 | $321.12 | $221.76 | $219.24 |
| Total debt | $291.63 | $290.43 | $190.67 | $190.64 |
| Total liabilities | $380.99 | $378.69 | $292.15 | $278.23 |
| Shareholders' equity | ||||
| Retained earnings | -$44.31 | -$34.42 | -$33.27 | -$33.68 |
| Other shareholder equity | -$0.04 | $0.02 | $0.03 | $0.03 |
| Total shareholder equity | $530.72 | $537.85 | $537.75 | $536.13 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Jan 2020 | |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $38.81 | $49.09 | $15.97 | |
| Short term investments | ||||
| Net receivables | $62.81 | $50.59 | $49.1 | |
| Inventory | $14.06 | $11.09 | $3.3 | |
| Total current assets | $132.25 | $125.83 | $80.19 | |
| Long term investments | ||||
| Property, plant & equipment | $20.4 | $20.67 | $16.84 | |
| Goodwill & intangible assets | $675.22 | $694.05 | ||
| Total noncurrent assets | $697.65 | $717.24 | $736.59 | |
| Total investments | ||||
| Total assets | $829.9 | $843.07 | $816.78 | |
| Current liabilities | ||||
| Accounts payable | $13.87 | $21.31 | $7.37 | |
| Deferred revenue | $7.47 | $6.47 | $7.46 | |
| Short long term debt | $0.5 | $2.86 | ||
| Total current liabilities | $70.4 | $97.79 | $58.79 | |
| Long term debt | $190.17 | $240.42 | $217.25 | |
| Total noncurrent liabilities | $221.76 | $275.12 | $288.11 | |
| Total debt | $190.67 | $243.28 | ||
| Total liabilities | $292.15 | $372.92 | $346.91 | |
| Shareholders' equity | ||||
| Retained earnings | -$33.27 | -$23.29 | -$16.83 | |
| Other shareholder equity | $0.03 | $0.08 | $0.02 | |
| Total shareholder equity | $537.75 | $470.15 | ||
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $89.78 | $96.71 | $97.31 | $82.41 |
| Cost of revenue | $59.31 | $62.71 | $56.48 | $45.21 |
| Gross Profit | $30.48 | $33.99 | $40.83 | $37.2 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $24.09 | $23.21 | $23.11 | $21.3 |
| Total operating expenses | $38.86 | $32.11 | $33.84 | $29.1 |
| Operating income | -$8.38 | $1.89 | $6.99 | $8.1 |
| Income from continuing operations | ||||
| EBIT | -$8.38 | $1.89 | $7 | $8.1 |
| Income tax expense | -$2.68 | -$0.68 | $4.42 | $1.13 |
| Interest expense | $4.19 | $3.72 | $2.17 | $3.28 |
| Net income | ||||
| Net income | -$9.89 | -$1.15 | $0.41 | $3.69 |
| Income (for common shares) | -$9.89 | -$1.15 | $0.41 | $3.69 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Jan 2020 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $337.6 | $282.91 | $80.42 | |
| Cost of revenue | $195.32 | $171.3 | ||
| Gross Profit | $142.28 | $111.62 | $33.73 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $94.09 | $79.95 | ||
| Total operating expenses | $130.47 | $111.94 | $46.41 | |
| Operating income | $11.81 | -$0.32 | -$11.99 | |
| Income from continuing operations | ||||
| EBIT | $6.71 | $10.49 | ||
| Income tax expense | -$0.62 | -$1.9 | -$0.86 | |
| Interest expense | $17.31 | $18.86 | $5.76 | |
| Net income | ||||
| Net income | -$9.98 | -$6.46 | -$16.83 | |
| Income (for common shares) | -$9.98 | -$6.46 | ||
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Net income | -$9.89 | -$1.15 | $0.41 | $3.69 |
| Operating activities | ||||
| Depreciation | $10.42 | $9.5 | $7.81 | $7.47 |
| Business acquisitions & disposals | -$74.61 | |||
| Stock-based compensation | $2.87 | $1.26 | $1.21 | $1.09 |
| Total cash flows from operations | $1.89 | -$15.66 | $2.51 | $16.25 |
| Investing activities | ||||
| Capital expenditures | -$2.67 | -$2.94 | -$3.56 | -$2.51 |
| Investments | ||||
| Total cash flows from investing | -$2.67 | -$77.55 | -$3.56 | -$2.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.04 | -$0 | $1.36 | |
| Net borrowings | -$0.27 | $75.28 | -$0.13 | -$0.12 |
| Total cash flows from financing | -$0.31 | $75.28 | -$0.13 | $1.24 |
| Effect of exchange rate | -$0.06 | -$0.01 | -$0 | -$0.03 |
| Change in cash and equivalents | -$1.15 | -$17.95 | -$1.19 | $14.95 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Jan 2020 | |
|---|---|---|---|---|
| Net income | -$9.98 | -$6.46 | -$16.83 | |
| Operating activities | ||||
| Depreciation | $30.48 | $28.03 | ||
| Business acquisitions & disposals | -$3.76 | |||
| Stock-based compensation | $4.38 | $6.68 | ||
| Total cash flows from operations | -$2.31 | $31.56 | -$14.39 | |
| Investing activities | ||||
| Capital expenditures | -$12.33 | -$9.51 | ||
| Investments | ||||
| Total cash flows from investing | -$12.33 | -$13.27 | -$629.85 | |
| Financing activities | ||||
| Dividends paid | -$74.5 | |||
| Sale and purchase of stock | $147.74 | |||
| Net borrowings | -$58.53 | $21.3 | ||
| Total cash flows from financing | $4.41 | $9.43 | $665.57 | |
| Effect of exchange rate | -$0.04 | $0.02 | $0.02 | |
| Change in cash and equivalents | -$10.28 | $27.74 | $21.35 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 73.22M |
| Revenue | $366.21M |
|---|---|
| EBITDA | $43.81M |
| EBIT | $8.61M |
| Net Income | -$6.95M |
| Revenue Q/Q | 19.31% |
| Revenue Y/Y | 16.45% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 7.25 |
| Cash/Share | 0.27 |
| EPS | -$0.09 |
|---|---|
| ROA | -0.80% |
| ROE | -1.30% |
| Debt/Equity | 0.54 |
|---|---|
| Net debt/EBITDA | 8.25 |
| Current ratio | 2.20 |
| Quick ratio | 1.60 |